Found: 1

Select item for more details and to access through your institution.

  • A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 2, p. E54, doi. 10.1002/ajh.26420
    By:
    • Cornell, Robert Frank;
    • Baz, Rachid;
    • Richter, Joshua R.;
    • Rossi, Adriana;
    • Vogl, Dan T.;
    • Chen, Christine;
    • Shustik, Chaim;
    • Alvarez, Mariano J.;
    • Shen, Yao;
    • Unger, T. J.;
    • Ben‐Shahar, Osnat;
    • Wang, Hongwei;
    • Baloglu, Erkan;
    • Senapedis, William;
    • Ma, Xiwen;
    • Landesman, Yosef;
    • Bai, Xiang;
    • Bader, Justin;
    • Xu, Hongmei;
    • Marshall, Tracey
    Publication type:
    Article